8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O 6 -Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53

Bioeffects Seen

Authors not listed · 2021

Share:

50 Hz electromagnetic fields enhanced chemotherapy effectiveness against resistant brain cancer cells by modifying key tumor genes.

Plain English Summary

Summary written for general audiences

Researchers tested whether electromagnetic fields could help overcome chemotherapy resistance in aggressive brain cancer cells. They found that combining 50 Hz EMF exposure with the drug temozolomide killed more cancer cells and reduced their ability to spread. The electromagnetic fields appeared to make the chemotherapy more effective by changing how key cancer-related genes and proteins behaved.

Why This Matters

This study reveals a fascinating paradox in EMF research. While we typically focus on EMF's potential health risks, here we see 50 Hz electromagnetic fields potentially enhancing cancer treatment effectiveness. The frequency tested (50 Hz) is identical to the power grid frequency that surrounds us daily through household wiring and appliances. What makes this particularly intriguing is that the researchers used relatively low-intensity fields (70 Gauss) that enhanced the cancer drug's ability to kill resistant tumor cells. This doesn't mean power line EMF is beneficial for healthy people, but it does highlight how complex EMF's biological effects can be. The science demonstrates that electromagnetic fields can significantly alter cellular behavior and gene expression in ways that might be therapeutically useful under controlled medical conditions.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 50 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 50 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2021). Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O 6 -Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53.
Show BibTeX
@article{pulsed_and_discontinuous_electromagnetic_field_exposure_decreases_temozolomide_resistance_in_glioblastoma_by_modulating_the_expression_of_o_6_methylguanine_dna_methyltransferase_cyclin_d1_and_p53_ce4008,
  author = {Unknown},
  title = {Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O 6 -Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53},
  year = {2021},
  doi = {10.1089/cbr.2020.3851},
  
}
DOI: 10.1089/cbr.2020.3851PubMed: 32644826

Quick Questions About This Study

Yes, this study found that 50 Hz electromagnetic fields at 70 Gauss enhanced temozolomide chemotherapy effectiveness in glioblastoma cells. The combination treatment killed more cancer cells and reduced their migration compared to chemotherapy alone.
The research showed EMF exposure partially reduced temozolomide resistance in T98 glioblastoma cells by affecting MGMT protein expression, which is a key factor in chemotherapy resistance. This suggests EMF might help overcome treatment failure mechanisms.
The 70 Gauss electromagnetic field exposure increased p53 gene expression (a tumor suppressor) and decreased cyclin-D1 protein levels (involved in cell division). These changes help explain why the combination treatment was more effective at killing cancer cells.
The 50 Hz EMF exposure significantly decreased the migration potential of both T98 and A172 glioblastoma cell lines when combined with temozolomide treatment. Reduced cancer cell migration could potentially limit tumor spread and metastasis.
Yes, 70 Gauss EMF exposure enhanced cancer cell death and modified key tumor-related proteins in this study. This field strength is much higher than typical household exposure but demonstrates that specific EMF parameters can have measurable biological effects on cancer cells.